209 related articles for article (PubMed ID: 25575823)
1. DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance.
Huber RM; Lucas JM; Gomez-Sarosi LA; Coleman I; Zhao S; Coleman R; Nelson PS
Oncotarget; 2015 Feb; 6(4):2134-47. PubMed ID: 25575823
[TBL] [Abstract][Full Text] [Related]
2. DNA Damage Induces a Secretory Program in the Quiescent TME that Fosters Adverse Cancer Phenotypes.
Gomez-Sarosi L; Sun Y; Coleman I; Bianchi-Frias D; Nelson PS
Mol Cancer Res; 2017 Jul; 15(7):842-851. PubMed ID: 28356331
[TBL] [Abstract][Full Text] [Related]
3. GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.
Morandi A; Martin LA; Gao Q; Pancholi S; Mackay A; Robertson D; Zvelebil M; Dowsett M; Plaza-Menacho I; Isacke CM
Cancer Res; 2013 Jun; 73(12):3783-95. PubMed ID: 23650283
[TBL] [Abstract][Full Text] [Related]
4. Effect of brefelamide on proliferation of 1321N1 human astrocytoma cells induced by glial cell line-derived neurotrophic factor.
Honma S; Kouno K; Takasaka S; Mitazaki S; Abe S; Kikuchi H; Oshima Y; Yoshida M
Pharmazie; 2018 Jan; 73(1):22-28. PubMed ID: 29441947
[TBL] [Abstract][Full Text] [Related]
5. GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance.
Kim M; Kim DJ
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617307
[TBL] [Abstract][Full Text] [Related]
6. Glial cell line-derived neurotrophic factor influences proliferation of osteoblastic cells.
Gale Z; Cooper PR; Scheven BA
Cytokine; 2012 Feb; 57(2):276-81. PubMed ID: 22142702
[TBL] [Abstract][Full Text] [Related]
7. A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer.
Esseghir S; Todd SK; Hunt T; Poulsom R; Plaza-Menacho I; Reis-Filho JS; Isacke CM
Cancer Res; 2007 Dec; 67(24):11732-41. PubMed ID: 18089803
[TBL] [Abstract][Full Text] [Related]
8. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
[TBL] [Abstract][Full Text] [Related]
9. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells.
Lee RH; Wong WL; Chan CH; Chan SY
J Neurosci Res; 2006 Jan; 83(1):80-90. PubMed ID: 16294336
[TBL] [Abstract][Full Text] [Related]
11. KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone.
Mavridis K; Talieri M; Scorilas A
Biol Chem; 2010 Apr; 391(4):467-74. PubMed ID: 20128692
[TBL] [Abstract][Full Text] [Related]
12. Paracrine regulation of glioma cells invasion by astrocytes is mediated by glial-derived neurotrophic factor.
Shabtay-Orbach A; Amit M; Binenbaum Y; Na'ara S; Gil Z
Int J Cancer; 2015 Sep; 137(5):1012-20. PubMed ID: 25487790
[TBL] [Abstract][Full Text] [Related]
13. Gdnf-Gfra1 pathway is expressed in a spermatogenetic-dependent manner and is regulated by Fsh in a fish testis.
Bellaïche J; Goupil AS; Sambroni E; Lareyre JJ; Le Gac F
Biol Reprod; 2014 Oct; 91(4):94. PubMed ID: 25165121
[TBL] [Abstract][Full Text] [Related]
14. Identification of docetaxel resistance genes in castration-resistant prostate cancer.
Marín-Aguilera M; Codony-Servat J; Kalko SG; Fernández PL; Bermudo R; Buxo E; Ribal MJ; Gascón P; Mellado B
Mol Cancer Ther; 2012 Feb; 11(2):329-39. PubMed ID: 22027694
[TBL] [Abstract][Full Text] [Related]
15. CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity.
Qian DZ; Rademacher BL; Pittsenbarger J; Huang CY; Myrthue A; Higano CS; Garzotto M; Nelson PS; Beer TM
Prostate; 2010 Mar; 70(4):433-42. PubMed ID: 19866475
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: involvement of the insulin like growth factor-1 receptor.
Thomas F; Holly JM; Persad R; Bahl A; Perks CM
Prostate; 2010 Jun; 70(8):856-65. PubMed ID: 20127733
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathways: involving microenvironment damage responses in cancer therapy resistance.
Sun Y; Nelson PS
Clin Cancer Res; 2012 Aug; 18(15):4019-25. PubMed ID: 22619305
[TBL] [Abstract][Full Text] [Related]
18. Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs).
Rong G; Kang H; Wang Y; Hai T; Sun H
PLoS One; 2013; 8(8):e70960. PubMed ID: 23951052
[TBL] [Abstract][Full Text] [Related]
19. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
20. Effects of polychlorinated biphenyls (PCBs) on expression of neurotrophic factors in C6 glial cells in culture.
Gurley GH; Jelaso AM; Ide CF; Spitsbergen JM
Neurotoxicology; 2007 Nov; 28(6):1264-71. PubMed ID: 17888513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
